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IMPLICATIONS ANDPurpose: To investigate the effect of obesity at the start of adolescence on the prevalence, inci-
dence and maintenance of chest wheezing among individuals aged 11e15 years in a birth cohort in
a developing country.
Methods: The seventh follow-up of the 1993 Pelotas birth cohort occurred in 2004 (individuals
aged 10e11 years). Between January and August 2008, the eighth follow-up of the cohort was
conducted. All the individuals of the original cohort who were alive (who were then adolescents
aged between 14 and 15 years) were targets for the study. The International Study of Asthma and
Allergies in Childhood (ISAAC) questionnaire was used to deﬁne wheezing. In addition to the body
mass index (BMI), used to deﬁne obesity by the World Health Organization (WHO) criteria, we
assessed skinfold thickness.
Results: From the original cohort, 4,349 individuals were located (85.7% follow-up rate). The
prevalence of chest wheezing at 11 and 15 years were 13.5% (95% CI: 12.5%e14.5%) and 12.1% (95%
CI: 11.1%e13.1%), respectively. The prevalence of wheezing at both times was 4.5% (95% CI: 3.9%
e5.1%) and the incidence of wheezing was 7.5% (95% CI: 6.7%e8.3%). Independent of the effect
of various confounding variables, the prevalence of wheezing at 15 years was 50% greater among
obese individuals than among eutrophic individuals at 11 years (RR 1.53; 95% CI: 1.14e2.05). The
greater the skinfold tertile at 11 years, the higher the prevalence of wheezing at 15 years was
(p ¼ .011). Weight status and skinfolds did not present any association with incident wheezing.
After controlling for confounding factors, the risk of persistent wheezing among obese individuals
at 11 years was 1.82 (95% CI: 1.30e2.54).
Conclusions: Since obesity at the start of adolescence is associated with asthma symptom
persistence, prevention and treatment of obesity may reduce avoidable healthcare costs and
disease burden.
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Theprevalenceofwheezing
in the last 12 months at 11
and 15 years old was 4.5%.
The incidence of wheezing
from 11 to 15 years old
was 7.5%. Obesity was
associated with a higher
risk of wheezing in this
birth cohort. Prevention
and treatment of obesity in
adolescence may reduce
respiratory morbidity at
later ages.The incidence and prevalence of asthma symptoms remain
high throughout the Western world [1]. It is estimated that theprevalence of asthma in adolescents aged 13e14 years is 18.2% in
the southern region of Brazil [2]. Moreover, because of the various
morbid conditions associated with obesity, the increased body
mass index (BMI)observedamongtheyoungpopulation isamatter
of concern [3e5]. The effects of obesity on respiratory symptoms,
illustrated long ago by Charles Dickens in “The adventures of
R.B. Noal et al. / Journal of Adolescent Health 51 (2012) S38eS45 S39Mr. Pickwick,” have been studied for around half a century. Over
recent decades, associations between obesity and asthma have
begun to arouse greater discussion in the scientiﬁc media [6e8].
Today, obesity is described in the literature as one of the risk
factors for asthma development, together with sex and genetic
predisposition [9]. However, since a large proportion of the
knowledge about this association comes from studies with
a cross-sectional design, one of the most important criteria of
causality, i.e., temporality, is not taken into consideration [10e16].
Systematic reviews and meta-analyses on the few longitudinal
studies (which were all carried out in developed countries) have
found that the risk of asthma development is up to 50% greater
among obese individuals than among individuals who are
considered to be eutrophic [17e19]. From assumptions that the
prevalence of obesity among adult Americans was around 30%
and that the risk of asthma occurrence among obese individuals
was between 1.6 and 3.0. Ford et al. estimated that obesity could
be responsible for around 15% to 38% of asthma cases [20].
The high occurrence rates of obesity and asthma in this age
group, the lack of longitudinal studies conducted in developing
countries, and the potentiallymodiﬁable nature of risk factors for
asthma symptoms attributed to obesity were the justiﬁcations
for carrying out the present study. In this light, the aims of this
study were to investigate the effects of obesity at the start of
adolescence on the incidence, maintenance and prevalence of
chest wheezing at the age of 15 years among the 1993 birth
cohort of the city of Pelotas.
Method
The 1993 Pelotas (Brazil) Birth Cohort Study
In 1993, all births that occurred in all hospitals in Pelotasda
city of approximately 340,000 inhabitants in the southern
region of Brazildwere identiﬁed. The mothers answered a stan-
dardized questionnaire that sought information relating to the
gestational period, and the newborns were weighed immedi-
ately after delivery. Since then, this population has been followed
up periodically; details of the methodology used are available in
other published papers [21e23].
The follow-up
The seventh follow-up occurred in 2004 (individuals aged
10e11 years). Between January and August 2008, the eighth
follow-up of the cohort was conducted. All the individuals of the
original cohort who were alive (who were then adolescents aged
between 14 and 15 years) were targets for the study. During the
ﬁeldwork, two different teams with periodic training and stan-
dardization were used. One team was responsible for interviews
conducted inhomes and theother, for anthropometric evaluations
made at a measurement center; only adolescents who refused to
go to the center underwent anthropometric evaluations at home.
The outcomes
The questionnaire of the “International Study of Asthma and
Allergies in Childhood Steering Committee” (ISAAC), which had
already been validated in Brazil, was used to assess the outcome
[24,25]. Through the questions “Since<MONTH> of last year has
<NAME> had chest wheezing?”, which had been applied to the
mother in 2004, and “Since <MONTH> of last year have you hadchest wheezing?”, which was applied to the adolescent in 2008,
the prevalence of chest wheezing at the ages of 11 and 15 years,
respectively, were determined. With the aim of evaluating the
trajectory of wheezing over the follow-up periods, three main
outcomes were deﬁned: prevalence of wheezing at 15 years of
age; incident wheezing (individuals whose mothers had not re-
ported any presence of wheezing at the age of 11 years but who
themselves reported at the follow-up at the age of 15 years that
wheezing was occurring); and persistent wheezing (those who
presented chest wheezing at both follow-ups, i.e., who continued
to present wheezing). The reference categories for analyzing
incident wheezing and persistent wheezing were adolescents
who did not present wheezing at the ages of 11 years and 15
years, and adolescents who presented wheezing at 11 years of
age but not at 15 years of age, respectively.
The anthropometric variables
The anthropometric variables of the study were deﬁned
through the means from two measurements of weight (using
a Tanita digital balance with accuracy of 100 grams), height
(using an aluminum stadiometer), and the triceps and sub-
scapular skinfolds (Cescorf skinfold caliper, with accuracy of one
millimeter), whichweremade during the follow-ups in 2004 and
2008 [26]. The BMI was then calculated in accordance with the
reference values of the World Health Organization (WHO) for
children and adolescents of school age [27]. These criteria classify
individuals between the ages of 5 and 19 years according to the
BMI Z-scores for age and sex. Because of the small number of
individuals with Z-scores less than 1, the category “thin” was
not used. Thus, individuals with Z-scores of up to þ1 standard
deviation (SD) were considered to be “normal”; those with
Z-scores greater than one and up to þ2 SDs were considered to
present “overweight”; and those with Z-scores higher than þ2
SDs were considered to be “obese.”
The trajectory variables
With the aim of evaluating the trajectory of obesity from 11 to
15 years of age, the variable “trajectory of obesity”was created. This
was categorized as neverobese (noobesityeither at 11or at 15years
of age); obese at 11 and nonobese at 15 years; nonobese at 11 years
and obese at 15 years; and always obese, i.e., at both follow-up
times. Through summing the triceps and subscapular skinfold
values (using the means from three measurements), the variable
“skinfold sum at 11 years of age” was generated, and this was
subsequentlycategorized intotertiles.The trajectoryof the skinfolds
at the two follow-upswasevaluated inﬁve categories:maintenance
in the ﬁrst tertile; reduction of tertile; maintenance in the middle
tertile; increase of tertile; and maintenance in the upper tertile.
The confounding factors
To control for possible confounding factors, demographic
characteristics (sex and self-reported skin color) and data
relating to themother’s pregnancy and puerperal period that had
been gathered in 1993 (maternal smoking during pregnancy,
mother’s age at delivery and newborn’s gestational age) were
used. Reasons for hospital admission during the ﬁrst year of life
were used as controls. The socioeconomic variable was based on
changes in family income (described in terms of numbers of
minimum salaries) between birth and 15 years of age and
Table 1
Description of the variables studied and comparisonwith the original population
from the 1993 Pelotas (Brazil) Birth Cohort Study
Characteristic Original N (%) Traced in
2008 N (%)
Sex 5,248 4,018
Male 2,606 (49.7) 1,966 (48.9)
Female 2,642 (50.3) 2,052 (51.1)
Skin color 4,420 4,001
White 2,953 (66.8) 2,646 (66.1)
Black or mixed 1,259 (28.5) 1,165 (29.1)
Other 208 (4.7) 190 (4.8)
Maternal smoking during pregnancy 5,249 4,018
No 3,497 (66.6) 2,683 (66.8)
Yes 1,752 (33.4) 1,335 (33.2)
Maternal age at delivery (years) 5,248 4,017
<20 915 (17.4) 692 (17.2)
20e34 3,756 (71.6) 2,884 (71.8)
35 577 (11.0) 441 (11.0)
Gestational age (weeks) 5,193 3,981
37 4,582 (88.2) 3,558 (89.4)
<37 611 (11.8) 423 (10.6)
Hospitalizations in the ﬁrst year 5,249 4,018
No 4,297 (81.9) 3,323 (82.7)
Diarrhea, ARI, or bronchospasm 430 (8.2) 324 (8.1)
Another reason 522 (9.9) 371 (9.2)
Parents smoking in 2004 3,382 3,073
No one 785 (23.2) 714 (23.2)
At least one former smoker 932 (27.6) 862 (28.1)
At least one smoker 1,034 (30.6) 935 (30.4)
Both smoker 631 (18.6) 562 (18.3)
Family history of asthma, wheezing,
or bronchitis
4,356 3,947
No 2,856 (65.6) 2,587 (65.5)
Yes 1,500 (34.4) 1,360 (34.5)
Number of people co-sleeping with
adolescent
4,425 4,008
Nobody 1,175 (26.6) 1,054 (26.3)
One to three 2,868 (64.8) 2,617 (65.3)
Four or more 382 (8.6) 337 (8.4)
Number of days with GERD symptoms
weekly
4,324 4,015
None 3,631 (84.0) 3,377 (84.1)
One day 460 (10.6) 428 (10.7)
Two or more days 233 (5.4) 210 (5.2)
Medical diagnosis of allergy (rhinitis
and/or eczema)
4,214 3,976
No 1,956 (46.4) 1,831 (46.1)
Rhinitis or eczema 1,812 (43.0) 1,731 (43.6)
Rhinitis and eczema 446 (10.6) 413 (10.3)
Physical activity trajectory from 11 to
15 years old
4,092 3,880
Inactive in both periods 1,549 (37.9) 1,459 (37.6)
Active only at 11 years 871 (21.3) 830 (21.4)
Active only at 15 years 826 (20.1) 785 (20.2)
Active in both waves 846 (20.7) 806 (20.8)
Family income from birth to 15 years old 4,224 .922
Ever poor 876 (20.8) 809 (20.7)
Not poorepoor 540 (12.8) 503 (12.9)
Poorenot poor 941 (22.2) 874 (22.3)
Never poor 1,867 (44.2) 1,726 (44.1)
Tanner’ pubertal stages (score) 3,442 3,250
2e4 (least developed) 191 (5.6) 176 (5.3)
5e7 1,691 (49.1) 1,597 (49.2)
8e10 (most developed) 1,560 (45.3) 1,477 (45.5)
Adolescent smoking trajectory at 11 and
15 years old
4,135 3,952
Noeno 3,310 (80.1) 3,173 (80.3)
Yeseno 53 (1.2) 49 (1.2)
Noeyes 675 (16.3) 635 (16.1)
Yeseyes 97 (2.4) 95 (2.4)
ARI ¼ acute respiratory infection; GERD ¼ gastroesophageal reﬂux disease.
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poor; poor to not poor; never poor. At the follow-up in 2004, the
following were assessed: household density, i.e., the number of
people who slept in the same bedroom as the adolescent in
question; the parents’ smoking habit; and any family history of
asthma or chest wheezing or bronchitis.
At the follow-up in 2008, the following were included as
possible confounding factors: number of symptoms of gastro-
esophageal reﬂux disease (GERD)[28] seen per week and,
through a conﬁdential questionnaire, sexual maturation
according to the Tanner stages (categorized sum of points
relating to development of pubic hair and penis/breasts) [29,30].
From the information obtained at the follow-ups in 2004 and
2008, the trajectory of the adolescent’s variables of smoking and
physical activity, deﬁned threshold of at least 300 minutes per
week, was ascertained (not present either in 2004 or in 2008;
present only in 2004; present only in 2008; present both in
2004 and 2008) [31]. The trajectory of medical diagnoses of
allergy was also ascertained (without any medical diagnosis of
rhinitis or eczema at either follow-up; rhinitis or eczema at one
of the follow-ups; rhinitis and eczema at both follow-ups). In
addition to the above variables, breastfeedingdduring the
ﬁrst year of life, exclusive breastfeeding, and predominant
breastfeedingd(1993e94), contact with cats or dogs (1997e98),
age at menarche (2008) and use of medications over the two
weeks preceding the interview (2008) were also evaluated as
possible confounders.
The statistical analysis
The data were double-entered into the Epi-Info 6.0 software
and were analyzed using the Stata 9.0 statistical package
(StataCorp, College Station, TX). Bivariate analysis, with calcula-
tion of proportions and 95% conﬁdence intervals (95% CI), was
performed using the chi-square test for heterogeneity or linear
trend. Multivariable analysis to control for possible confounding
factors was performed by means of Poisson regression, with
robust adjustment for variance. The results were presented as
prevalence or incidence ratios and the 95% CI. Since the effect of
the exposures analyzed did not differ according to sex or socio-
economic level (p for interaction >.10), it was not necessary to
stratify the analyses according to these variables. The signiﬁ-
cance level for the two-tailed tests was taken to be 5%.
Ethical aspects
The parents or guardians signed an informed consent state-
ment and assurances were provided regarding data conﬁdenti-
ality. The study was approved by the Research Ethics Committee
of the Federal University of Pelotas, which is afﬁliated with the
Brazilian National Research Ethics Council (CONEP).
Results
The 1993 Pelotas (Brazil) Birth Cohort Study
Out of the 5,249 members of the original cohort, 4,201 indi-
viduals were located (excluding 148 deaths), which corre-
sponded to a follow-up rate at 15 years of age of 85.7%. Table 1
describes the distribution of the variables used for controlling
for confounding factors in relation to the original cohort pop-
ulation and the population located at the age of 15 years. The
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inal cohort and cohort followed up was less than one percentage
point. Among the individuals accompanied at the age of 15 years,
just over half were female; most were white-skinned; one ﬁfth
had always been poor; approximately 60% were inactive at the
age of 15 years; almost half of them said that they had had
a medical diagnosis of allergies; and just over 80% said that they
had never smoked.Weight status and wheezingdcrude analysis
At the age of 11 years, approximately one third of the
adolescents in the cohort had presented overweight or obesity
(Table 2). At the next follow-up, less than 3% of the adolescents
had become obese, while just over 6% remained obese. Almost
one quarter of the adolescents remained in the upper tertile of
the skinfold sum. The prevalence of chest wheezing at 11 and 15
years of age were 13.5% (95% CI: 12.5%e14.5%) and 12.1% (95% CI:
11.1%e13.1%), respectively. In relation to the adolescents who had
not presented wheezing at 11 years of age, 8.7% (95% CI:
7.8%e9.6%) of the adolescents presented incident wheezing. In
relation to the adolescents who had presented wheezing at 11
years of age, 33.4% (95% CI: 29.5%e37.3%) of the adolescents
presented persistent wheezing. The presence of wheezing at the
age of 15 years was greater among obese individuals than among
nonobese individuals. Likewise, it was observed that the preva-
lence of wheezing at 15 years of age tended to be higher if the
tertile of the skinfold sum presented at the age of 11 years had
increased.
The weight status and skinfolds at 11 years of age, the trajec-
tory of obesity and the trajectory of skinfolds from 11 to 15 years
of age were not signiﬁcantly associated with incident wheezing.
Obese adolescents and those in the upper tertile of skinfolds
presented greater occurrence of persistent wheezing. SimilarTable 2
Prevalence of wheezing at 11 years old and at 15 years old, incident wheezing and pe
(Brazil) Birth Cohort Study
N (%) Prevalence of wheezing
at 11 years (2004) (IC95%)
Occurrences 13.5 (12.5; 14.5)
Weight status at 11 years old 4,441 .003a
Normal 3,080 (69.3) 12.6 (11.4; 13.8)
Overweight 888 (20.0) 13.9 (11.6; 16.2)
Obese 473 (10.7) 17.8 (14.3; 21.3)
Sum of skinfolds at 11 years old
(tertile)
4,424 .207a
First 1,485 (33.6) 13.4 (11.7; 15,1)
Second 1,465 (33.1) 11.9 (10.2; 13.6)
Third 1,474 (33.3) 15.0 (13.2; 16.8)
Obesity trajectory from 11 to
15 years old
4,032 .026b
NoeNo 3,498 (86.8) 13.2 (12.0; 14.3)
YeseNo 181 (4.5) 19.9 (14.0; 25.8)
NoeYes 102 (2.5) 12.7 (6.2; 19.3)
YeseYes 251 (6.2) 17.1 (12.4; 21.8)
Skinfolds trajectory from 11 to
15 years old
4,030 .046b
Ever in the lowest tertile 923 (22.9) 13.8 (11.5; 16.0)
Reduction of tertile 754 (18.7) 16.1 (13.5; 18.7)
Ever in the middle tertile 650 (16.1) 11.5 (9.0; 13.9)
Increase of tertile 769 (19.1) 11.9 (9.6; 14.2)
Ever in the highest tertile 934 (23.3) 14.9 (12.6; 17.2)
a Test for linear trend.
b Test for heterogeneity.to what was observed with the skinfold tertiles, persistent
wheezing was present in almost one third of the eutrophic indi-
viduals and in half of the obese individuals at the start of
adolescence (p¼ .009). Approximately half of the individualswho
remained obese and just over 40% of those who remained in the
upper tertile of skinfolds reported having persistent wheezing.Weight status and wheezingdadjusted analysis
Table 3 shows that the prevalence of wheezing at the age of 15
years was 50% greater among the obese individuals than among
the eutrophic individuals at the age of 11 years (p ¼ .004). The
higher the skinfold tertile at 11 years of age, the greater the
prevalence of wheezing at 15 years of age (p ¼ .011). Both in the
crude and in the adjusted analysis, weight status and skinfolds
were not associated with incident wheezing. After controlling for
confounding factors, the risk of persistent wheezing among
obese individuals at the age of 11 years almost doubled. More-
over, it was observed that negative confounding occurred inmost
of the analyses, since the adjusted effect estimate was greater
than the crude measurement. Individuals who remained obese
presented a chance of persistent wheezing that was approxi-
mately 80% greater (independent of the effects of, for example,
sex, smoking, histories of allergies, and sexual development)
than what was seen among individuals who remained eutrophic
(p ¼ .011). Again, a similar effect was observed between the
skinfold categories at 11 years of age and the trajectory of
skinfolds.
The variables of breastfeeding, contact with cats or dogs, and
age at menarche did not present signiﬁcant associations with
weight status and the outcomes under assessment. At the age of
15 years, 37% of the adolescents reported that they had used
some type of medication within the last 15 days preceding thersistent wheezing according with weight status and skinfolds. The 1993 Pelotas
Prevalence of wheezing





12.1 (11.1; 13.1) 8.7 (7.8; 9.6) 33.4 (29.5; 37.3)
.042a .826a .009a
11.6 (10.5; 12.8) 8.8 (7.7; 9.9) 30.4 (25.6; 30.1)
11.6 (9.4; 13.7) 7.9 (6.0; 9.9) 34.5 (25.8; 43.1)
15.7 (12.4; 19.1) 9.1 (6.2; 12.0) 45.8 (34.8; 56.7)
.053a .611a .023a
11.0 (9.4; 12.6) 8.0 (6.5; 9.5) 29.7 (23.2; 32.2)
12.0 (10.3; 13.7) 9.6 (7.9; 11.3) 29.1 (22.1; 36.1)
13.4 (11.6; 15.2) 8.6 (7.0; 10.2) 40.2 (33.6; 46.8)
.071b .792b .066b
11.6 (10.5; 12.7) 8.6 (7.6; 9.6) 31.4 (27.1; 35.6)
16.1 (10.7; 21.5) 9.7 (4.8; 14.6) 41.7 (24.8; 58.6)
12.8 (6.2; 19.3) 11.2 (4.6; 17.9) 23.1 (-3.4; 49.6)
15.9 (11.4; 20.5) 9.1 (5.2; 13.1) 48.8 (33.3; 64.4)
.229b .894b .028b
11.5 (9.4; 13.5) 8.2 (6.3; 10.1) 32.3 (24.0; 40.5)
13.0 (10.6; 15.4) 8.7 (6.5; 10.9) 33.9 (25.3; 42.4)
10.9 (8.5; 13.3) 8.2 (6.0; 10.5) 32.4 (21.5; 43.4)
10.9 (8.7; 13.2) 9.5 (7.3; 11.7) 20.9 (12.4. 29.4)
13.9 (11.7; 16.1) 9.1 (7.1; 11.1) 41.7 (33.4; 50.0)
Table 3
Weight status and prevalence of wheezing at 15 years old, incident wheezing and persistent wheezing, crude and adjusted analyses. The 1993 Pelotas (Brazil) Birth
Cohort Study
Prevalence of wheezing at 15 years old Incident wheezing from 11 to 15 years Persistent wheezing at 11 and 15 years
Crude analysis Adjusted analysisa Crude analysis Adjusted analysisa Crude analysis Adjusted analysisa
Weight status at 11 years old .044b .004b .829b .583b .007b .001b
Normal 1.00 1.00 1.00 1.00 1.00 1.00
Overweight .99 (.81; 1.23) 1.19 (.92; 1.55) .90 (.68; 1.18) 1.07 (.76; 1.51) 1.14 (.85; 1.52) 1.28 (.90; 1.83)
Obese 1.35 (1.07; 1.71) 1.53 (1.14; 2.05) 1.03 (.73; 1.45) 1.11 (.72; 1.71) 1.51 (1.14; 2.00) 1.82 (1.30; 2.54)
Sum of skinfolds at 11 years old
(tertile)
.054b .011b .603b .505b .026b .001b
First 1.00 1.00 1.00 1.00 1.00 1.00
Second 1.09 (.89; 1.34) 1.07 (.80; 1.43) 1.20 (.93; 1.55) .94 (.65; 1.35) .98 (.71; 1.35) 1.48 (.92; 2.37)
Third 1.22 (1.00; 1.48) 1.41 (1.07; 1.84) 1.07 (.82; 1.40) 1.12 (.78; 1.60) 1.35 (1.03; 1.78) 1.91 (1.26; 2.88)
Obesity trajectory from 11 to
15 years old
.065c .083c .788c .398c .039c .011c
NoeNo 1.00 1.00 1.00 1.00 1.00 1.00
YeseNo 1.39 (.98; 1.96) 1.43 (.95; 2.17) 1.14 (.68; 1.89) 1.25 (.68; 2.31) 1.33 (.88; 2.00) 1.68 (1.00; 2.82)
NoeYes 1.10 (.66; 1.84) 1.39 (.74; 2.60) 1.31 (.73; 2.38) 1.71 (.88; 3.32) .74 (.27; 2.00) 1.00 (.18; 5.46)
YeseYes 1.37 (1.02; 1.85) 1.44 (1.01; 2.07) 1.07 (.68; 1.66) .99 (.56; 1.74) 1.56 (1.11; 2.18) 1.79 (1.20; 2.68)
Skinfolds trajectory from 11 to
15 years old
.229c .049c .894c .781c .039c .003c
Ever in the lowest tertile 1.00 1.00 1.00 1.00 1.00 1.00
Reduction of tertile 1.13 (.88; 1.47) 1.05 (.74; 1.51) 1.07 (.76; 1.51) .89 (.55; 1.44) 1.05 (.74; 1.50) 1.32 (.78; 2.23)
Ever in the middle tertile .95 (.72; 1.26) .97 (.65; 1.44) 1.01 (.70; 1.44) .77 (.45; 1.29) 1.00 (.66; 1.52) 1.45 (.84; 2.53)
Increase of tertile .95 (.73; 1.25) .82 (.55; 1.23) 1.16 (.84; 1.61) .94 (.58; 1.52) .65 (.40; 1.04) .49 (.22; 1.11)
Ever in the highest tertile 1.21 (.95; 1.54) 1.34 (.94; 1.92) 1.11 (.81; 1.53) 1.01 (.63; 1.64) 1.29 (.94; 1.78) 1.82 (1.10; 3.02)
a Adjusted for sex, skin color, maternal age at delivery, gestational age, hospitalization in infancy, maternal smoking during pregnancy, parents smoking at 11 and 15
years old, smoking trajectory of adolescent, income trajectory from birth to adolescence, family history of wheezing, medical diagnosis of allergy, physical activity
trajectory from 11 to 15 years old, gastroesophageal reﬂux disease, Tanner’s pubertal stage, and household density.
b Test for linear trend.
c Test for heterogeneity.
R.B. Noal et al. / Journal of Adolescent Health 51 (2012) S38eS45S42interview. Corticosteroid use was reported by only 41 adoles-
cents (.9%) and did not affect the estimates.
Discussion
In this birth cohort conducted in a developing country that
followed up adolescents from 11 to 15 years of age, it was
observed that obesity at the start of adolescence was associated
with occurrences of wheezing at 11 and 15 years of age and with
maintenance of wheezing from 11 to 15 years of age, indepen-
dent of various mediating and confounding factors. No associa-
tion between obesity at the start of adolescence and incident
wheezing was observed.
These ﬁndings gain importance because they came from
a population-based cohort that had been followed up at different
times, with low numbers of losses over the 15 years, as
demonstrated in Table 1. In the present study, the chance of
residual confounding was low because not only were the main
factors described in the literature as capable of mediating or
confounding the association between obesity and wheezing
taken into account, but also the confounding observed was
basically negative. It should also be emphasized that, in accor-
dance with guidance from WHO, quality control on BMI and
skinfold measurements was performed through standardization
and refreshment throughout the ﬁeldwork, which enabled an
adequate assessment of the presence of obesity.
On the other hand, we cannot fail to highlight the main
limitation of this study, which related to the diagnosing of
asthma. The deﬁnition of asthma put forward by the Global
Initiative for Asthma (GINA), i.e., that this is a disease with the
presence of chronic inﬂammation, hyperresponsiveness of thelower airways and airﬂow limitations that are reversible either
spontaneously or in response to use of a bronchodilator, is
unviable from an epidemiological point of view [32]. Because of
this, the diagnosing of asthma (which has repeatedly been cited
as the main limitation of studies) was done through medical
diagnostic reports or through self-reported symptoms or use of
medications for asthma. In order to identify individuals pre-
senting wheezing, which is the main symptom of asthma, it was
decided to apply the ISAAC questionnaire (which has been vali-
dated in several countries, including Brazil) because applying it
in epidemiological studies is feasible and its ﬁndings can be
compared with results already reported in the literature [24,33].
Because of the limitations related to diagnosing asthma, the term
“chest wheezing” was used as an outcome in the present study,
which corresponds to the description in the instrument used.
The presence of respiratory symptoms among obese individ-
uals, even in the absence of airﬂowobstruction or hyperreactivity,
may lead to errors in diagnosing asthma (misdiagnosis) in such
populations [34]. In the present study, among the individualswho
reported having received a medical diagnosis of asthma during
the preceding year, the proportions of reports of chest wheezing
were similar among normal, overweight, and obese individuals:
33%, 36%, and 37%, respectively (data not shown). Thus, weight
status is not believed to have interfered with the association
between wheezing and the medical diagnosis of asthma. This
observation is in agreementwith Aaron et al. [35], who suggested
that with the exception of symptoms reported in visits to the
emergency services, a situation in which the chance of mis-
diagnosing asthma is four times greater among obese individuals,
overdiagnosing of asthma occurs similarly among obese and
nonobese individuals [35,36]. Therefore, it is unlikely that the
Prevalence of obesity at 






















None 11 years only 15 years only 11 and 15 years
Chest Wheezing 
P-value = 0.17 (Wald test)
Figure 1. Prevalence of obesity at 15 years old (outcome) according to chest wheezing history (exposure). The 1993 Pelotas (Brazil) Birth Cohort Study.
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to any differential error regarding occurrences of chest wheezing.
Given that corticosteroid use is associated both with asthma
and with obesity, it has been debated in the literature whether
using this medication (which is preferred for treating persistent
asthma) might not be a confounding factor [32]. In the present
study, inclusion of the variable of corticosteroid use in the
analysis model produced negative confounding, i.e., the mea-
surements of the effect of obesity on occurrences of wheezing
increased after adjustment for this variable. However, in agree-
ment with another study conducted in Latin America, where the
use of inhaled corticosteroids was low, less than 1% of the
adolescents in this cohort reported having made use of this
medication. As the proportion of inhaled corticosteroid use was
similar between obese and nonobese patients, we decided to
exclude this variable from the model [37].
Over the years, cross-sectional and case-control studies have
consistently demonstrated, among a variety of populations and
ages, especially in adults, that there is an association, often with
dose-response effects, between increased BMI and occurrences
of respiratory symptoms [20,38e40]. In our study, it was
observed that obesity at the age of 11 years presented an asso-
ciation with wheezing at this age. However, obesity at the age of
15 years did not present an association with the prevalence of
wheezing at the age of 15 years (data not show). These ﬁndings
may suggest that obesity has greater inﬂuence during childhood
and at the start of adolescence, regarding occurrences of asthma
[41,42]. However, cross-sectional analyses have a limited
capacity for afﬁrming causality.
In a longitudinal study, Chinn and Rona observed that chil-
dren who were obese at 5e6 years of age presented a risk of
asthma at 10e11 years of age that was four times greater than
shown by those with normal BMI at the start of the follow-up
[42]. In the same paper, these authors emphasized the possi-
bility that an epiphenomenon might have occurred, because
certain risk factors were shared and because of the perception
that the prevalence of these two conditions tended to increase in
parallel [42]. Subsequently, the same authors further suggested
that asthma might cause obesity through the use of medications,
social stigma, and low physical capacity [43]. However, other
longitudinal studies carried out in developed countries have
suggested that obesity should be taken to be a risk factor for
incident and persistent asthma [41,44,45].In the present study, following up individuals from the start of
adolescence to the age of 15 years made it possible to investigate
certain facets of the association between obesity and wheezing.
With the speciﬁc objective of investigating the possibility of bi-
directionality, a stratiﬁed analysis on the trajectory of wheezing
from 11 to 15 years of age was used to evaluate the risk of
occurrence of obesity at 15 years of age (Figure 1). It was
observed that since the risk of being obese did not differ between
the categories of wheezing, occurrences of asthma at the start of
adolescence did not seem to alter the natural history of obesity.
This observation reinforces the direction of the association
between obesity and asthma, thus suggesting that the causal
chain during adolescence is unidirectional.
After the unidirectional nature of the relationship had been
conﬁrmed, the effect of obesity on wheezing was investigated.
Longitudinal analysis showed that the risk of persistent
wheezing (which was present in one third of the adolescents
with wheezing at the age of 11 years) was 80% greater among
obese individuals than among eutrophic individuals, after
controlling for confounding factors. In agreement with the
literature, this suggests that obesity is associated with mainte-
nance and severity of asthma [44,46,47]. However, contrary to
some studies [45,48], no association was observed between
obesity at the start of adolescence and incident asthma. The time
of life at which obesity has greatest impact on the risk of asthma
developmentmay be one of the key points in this question. In the
cohort, the effect of obesity at 11 years of age on maintenance of
wheezing occurred independently of obesity at the age of four
years (data not shown) and at 15 years, confounding and medi-
ating factors, respectively. In addition, after controlling for these
factors, it was observed that individuals who were obese at the
age of 11 years presented a risk of persistent wheezing that was
almost three times greater (RR 2.8; 95% CI: 1.7e4.7) than among
eutrophic individuals (data not shown). These data may suggest
that the most sensitive time is the start of adolescence: a period
that is characterized by intense hormonal and metabolic trans-
formation. Some authors have investigated an association
between earlymenarche and asthma symptoms, and the effect of
obesity on this relationship [44,49]. In the present study, the
association between obesity and persistent wheezing occurred
independently of the degree of sexual maturity at the age of 11
years. In fact, the controls increased risk from 50% to 60% among
the obese 11 year olds. On the other hand, these data do not rule
R.B. Noal et al. / Journal of Adolescent Health 51 (2012) S38eS45S44out the possibility that the lack of any association may have been
due to the need for a longer follow-up period for respiratory
symptoms to develop.
The ﬁnding that obesity precedes asthma led us to investigate
whether the effect observed might not have occurred because of
some other confounding factor. Given that many conditions have
been recognized as associated with developing and triggering
asthma [9], it is understandable that lack of control for several of
these might frequently be cited as limitations in studies on
obesity and asthma. In the present study, controlling for poten-
tial confounding factors helped to clarify some of the doubts in
the literature. It could be seen that negative confounding existed,
independent of the combined effect of variables such as: sex,
trajectory of family income, exposure to certain allergens,
exposure to smoking, physical activity, histories of allergy,
respiratory illnesses and reﬂux symptoms. This was shown by
the fact that inclusion of these variables in the model caused an
increase in the risks of wheezing associated with obesity. Inclu-
sion of breastfeeding and contact with cats and dogs separately
in the model also produced negative confounding (data not
shown).
In practically all the analyses, there was consistency between
the results found for the exposure variables (WHO weight status
and skinfold tertile) and the wheezing variables. It was observed
that in relation to the reference categories, not only the indi-
viduals who were obese or in the upper tertile of skinfolds at 11
years of age, but also those who remained obese or remained in
the upper tertile of skinfolds between the follow-ups, presented
a greater risk of persistent wheezing.
Several hypotheses have sought to explain the mechanisms
through which obesity is associated with asthma. It has been
suggested that the asthma phenotype might be affected by
obesity through direct mechanical effects, increased immune
response, genetic mechanisms, or hormonal inﬂuences [50,51].
However, because of the reduction in lung volume, lack of
eosinophilic inﬂammatory response, and differences in thera-
peutic response, with resistance to corticosteroids and greater
difﬁculty in achieving control, Beuther proposed that asthma in
obese individuals should be considered to be a new phenotype
[52]. Environmental factors such as physical activity, diet, and
birth weight may be connected with obesity, and combinations
of these factors with genetic susceptibility may cause increased
risk of asthma [53e55]. However, more than being a risk factor in
isolation, obesity may be a lifestyle marker, insofar as the envi-
ronment within which obese individuals live (diet, lack of exer-
cise, and lower physical capacity) may explain the presence and/
or worsening of asthma symptoms [42,56]. To expand the
approach towards the public health problem of asthma, Brisbon
et al. proposed that the concept of the built environment should
include not only the air quality but also personal attitudes
and diet [57].
Worldwide, occurrence of obesity and asthma in adult pop-
ulations has reached epidemic proportions, becoming a great
concern for the scientiﬁc community [1,58]. Within this pop-
ulation, measures targeting weight loss have caused reduction in
the occurrence of asthma symptoms and severity [59,60].
Considering that overweight or obese adolescents have a higher
risk of obesity in adulthood in relation to nonobese, we must
focus on preventive measures in the former population [61].
Therefore, particularly at early adolescence, obesity should be
considered a modiﬁable risk factor that may contribute to
reducing the occurrence and persistence of asthma.Acknowledgments
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